Acne Medication Market - By Formulation (Topical, Oral), By Product (Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, Azelaic Acid), By Type (Prescription, OTC), By Acne (Inflammatory, Non-Inflammatory), By Distribution Channel & Forecast, 2023-2032

Acne Medication Market Size

Acne Medication Market size exceeded a valuation worth USD 9.9 billion in 2022 and is projected to witness over 5.5% CAGR from 2023 to 2032.
 

A noticeable surge in the number of people dealing with severe acne issues may stimulate demand for acne medication over the forthcoming years. A number of factors, including smoking, excessive sebum secretion, unhealthy dietary habits, and hormonal changes, may result in acne breakouts.
 

Potential side effects may hamper the market development

Acne medication products come in varied strengths and formulations that may cause potential side effects, such as irritation, skin dryness, abnormal skin peeling, redness, mild burning or stinging sensation, etc., on several skin types. These may hamper the acne medication industry progress. Besides, an increasing number of generic medicine and pharmaceutical manufacturers making their foray into the market has resulted in rigorous price competition, which may further impact the market dynamics.
 

Acne Medication Market Analysis

Acne medication market from oral segment is expected to expand at over 6% CAGR between 2023 and 2032. Oral formulations are prescribed to reduce bacterial outgrowth and treat moderate to severe acne due to their high efficacy and better clinical outcomes. Oral therapeutics target acne-causing bacteria in and around the follicles to decrease sebum production and reduce inflammation. The increasing incidences of people suffering from severe and inflammatory acne manifested as nodules or cysts will drive segmental gains.
 

Acne medication market from retinoids segment was worth over USD 2.8 billion in 2022. Retinoids are found effective in treating moderate to severe acne, which has not responded well to other treatments. These products help prevent clogged pores and get rid of dead skin cells, thus enabling other topical formulations to work better. The high efficacy and versatility of retinoid pills in treating severe acne issues and reducing outbreaks will propel segment share.
 

Acne medication market from prescription segment amassed more than 54% business share in 2022 and is expected to record significant valuation by 2032. Prescription acne medications are recommended by dermatologists to control acne breakouts, minimize the prospects of scarring and skin damage, and reduce the visibility of scars. These include several oral antibiotic medicines and topical ointments & lotions containing salicylic acid, azelaic acids, benzoyl peroxide, retinoids, and others. The increasing utilization of a broad spectrum of prescription medications to get rid of severe acne and scar problems will drive the market statistics.
 

Acne medication market from inflammatory acne segment was valued at over USD 5.6 billion in 2022 and is predicted to garner appreciable gains through the forecast period. Inflammatory acne is a painful skin condition recognized by redness, swelling, and pores clogged with oil, bacteria, and dead skin cells. Several studies have addressed that acne may affect people's psychological well-being and can lead to conditions such as loss of self-identity, self-esteem, depression, anxiety, and suicidal tendency, bolstering the market share.
 

Acne medication market from pharmacies and drug store segment is expected to exhibit over 5.5% CAGR from 2023 to 2032 owing to the easy accessibility and expanding network of pharmacies and drug stores across several economies. Furthermore, an increasing number of pharmacies expanding their geographical footprints in remote locations will drive product sales.
 

Europe acne medication market is slated to garner more than USD 2.4 billion by 2032. This is attributed to the increasing acne-prone population, rising income levels, and the growing consciousness regarding the overall appearance among individuals. Besides, the availability of skilled dermatologists and the rise in expenditure on beauty and aesthetics will strengthen the regional market landscape.
 

Acne Medication Market Share

Major enterprises operating in the acne medication sector are:

• Allergan (AbbVie)
• Galderma S.A
• Reckitt Benckiser Group plc
• Bausch Health
• Stiefel Laboratories (GlaxoSmithKline plc)
• Bayer AG
• Almirall SA
• Paratek Pharmaceuticals
• Teva Pharmaceutical Industries
• Akorn Operating LLC 
• Sun Pharmaceuticals
• Pfizer Inc
• Viatris
• Mayne Pharmaceuticals
• Procter & Gamble.
   

Impact of COVID-19 Pandemic

The COVID-19 pandemic had a number of direct and indirect negative impacts on the acne medication industry. The massive surge in COVID infections collapsed the then-existing healthcare infrastructure. Besides, the growing severity of the crisis resulted in the delay and cancellation of previously scheduled appointments for acne treatment procedures. National authorities declared dermatological examinations as an elective and non-essential medical procedure, which further limited patient footfalls in hospitals and clinical settings. That being said, with the situation now returning to normal gradually, the industry is set to witness remarkable growth.
 

The acne medication market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2028 to 2032 for the following segments:

Click here to Buy Section of this Report

By Formulation

• Topical
• Oral

By Product

• Retinoids
• Antibiotics
• Salicylic Acid
• Benzoyl Peroxide
• Azelaic Acid
• Others

By Type

• Prescription
• OTC

By Acne Type

• Inflammatory Acne
• Non-Inflammatory Acne

By Distribution Channel

• Retail Stores
• Pharmacies & Drug Stores
• E-commerce

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia 
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE